Wells Fargo’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10
Closed -$50 7218
2024
Q1
$50 Hold
10
﹤0.01% 6438
2023
Q4
$69 Sell
10
-666
-99% -$4.6K ﹤0.01% 6414
2023
Q3
$6.19K Buy
676
+66
+11% +$604 ﹤0.01% 5547
2023
Q2
$12.9K Buy
610
+9
+1% +$190 ﹤0.01% 5539
2023
Q1
$16.2K Buy
601
+201
+50% +$5.41K ﹤0.01% 5391
2022
Q4
$14.2K Sell
400
-107
-21% -$3.79K ﹤0.01% 5089
2022
Q3
$114K Buy
507
+18
+4% +$4.05K ﹤0.01% 4251
2022
Q2
$93K Sell
489
-385
-44% -$73.2K ﹤0.01% 4426
2022
Q1
$218K Sell
874
-360
-29% -$89.8K ﹤0.01% 4635
2021
Q4
$192K Sell
1,234
-344
-22% -$53.5K ﹤0.01% 4922
2021
Q3
$316K Buy
1,578
+1,236
+361% +$248K ﹤0.01% 4629
2021
Q2
$87K Sell
342
-179
-34% -$45.5K ﹤0.01% 5035
2021
Q1
$138K Sell
521
-365
-41% -$96.7K ﹤0.01% 5005
2020
Q4
$326K Buy
886
+343
+63% +$126K ﹤0.01% 4721
2020
Q3
$132K Sell
543
-150
-22% -$36.5K ﹤0.01% 4967
2020
Q2
$199K Buy
693
+64
+10% +$18.4K ﹤0.01% 4753
2020
Q1
$128K Sell
629
-35
-5% -$7.12K ﹤0.01% 4758
2019
Q4
$297K Sell
664
-33
-5% -$14.8K ﹤0.01% 4602
2019
Q3
$214K Buy
697
+638
+1,081% +$196K ﹤0.01% 4750
2019
Q2
$19K Sell
59
-523
-90% -$168K ﹤0.01% 5445
2019
Q1
$244K Sell
582
-78
-12% -$32.7K ﹤0.01% 4654
2018
Q4
$200K Buy
660
+539
+445% +$163K ﹤0.01% 4717
2018
Q3
$44K Sell
121
-4
-3% -$1.46K ﹤0.01% 5331
2018
Q2
$46K Hold
125
﹤0.01% 5340
2018
Q1
$37K Buy
125
+17
+16% +$5.03K ﹤0.01% 5347
2017
Q4
$45K Sell
108
-71
-40% -$29.6K ﹤0.01% 5298
2017
Q3
$59K Buy
179
+50
+39% +$16.5K ﹤0.01% 5149
2017
Q2
$31K Buy
129
+4
+3% +$961 ﹤0.01% 5230
2017
Q1
$43K Buy
125
+25
+25% +$8.6K ﹤0.01% 5193
2016
Q4
$35K Sell
100
-1
-1% -$350 ﹤0.01% 5194
2016
Q3
$41K Buy
101
+98
+3,267% +$39.8K ﹤0.01% 5121
2016
Q2
$2K Sell
3
-22
-88% -$14.7K ﹤0.01% 5645
2016
Q1
$12K Sell
25
-12
-32% -$5.76K ﹤0.01% 5410
2015
Q4
$25K Sell
37
-1
-3% -$676 ﹤0.01% 5279
2015
Q3
$18K Buy
38
+26
+217% +$12.3K ﹤0.01% 5325
2015
Q2
$7K Sell
12
-196
-94% -$114K ﹤0.01% 5667
2015
Q1
$1.77M Sell
208
-3
-1% -$25.5K ﹤0.01% 3082
2014
Q4
$1.85M Buy
211
+15
+8% +$132K ﹤0.01% 3038
2014
Q3
$924K Buy
196
+194
+9,700% +$915K ﹤0.01% 3489
2014
Q2
$16K Buy
+2
New +$16K ﹤0.01% 5316